DK331387A - Praeparat til forhindring af metastase - Google Patents

Praeparat til forhindring af metastase

Info

Publication number
DK331387A
DK331387A DK331387A DK331387A DK331387A DK 331387 A DK331387 A DK 331387A DK 331387 A DK331387 A DK 331387A DK 331387 A DK331387 A DK 331387A DK 331387 A DK331387 A DK 331387A
Authority
DK
Denmark
Prior art keywords
metastase
prevention
preparation
Prior art date
Application number
DK331387A
Other languages
English (en)
Other versions
DK331387D0 (da
Inventor
Irun R Cohen
Israel Vlodavsky
Amiram Eldor
Yaakov Naparstek
Original Assignee
Hadassah Med Org
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadassah Med Org, Yeda Res & Dev filed Critical Hadassah Med Org
Publication of DK331387D0 publication Critical patent/DK331387D0/da
Publication of DK331387A publication Critical patent/DK331387A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK331387A 1986-06-26 1987-06-26 Praeparat til forhindring af metastase DK331387A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79255A IL79255A0 (en) 1986-06-26 1986-06-26 Composition for metastasis prevention

Publications (2)

Publication Number Publication Date
DK331387D0 DK331387D0 (da) 1987-06-26
DK331387A true DK331387A (da) 1987-12-27

Family

ID=11056897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK331387A DK331387A (da) 1986-06-26 1987-06-26 Praeparat til forhindring af metastase

Country Status (7)

Country Link
US (1) US4882318A (da)
EP (1) EP0254067A3 (da)
JP (1) JPS6388128A (da)
AU (1) AU7470587A (da)
DK (1) DK331387A (da)
IL (1) IL79255A0 (da)
NO (1) NO872674L (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262403A (en) * 1986-03-10 1993-11-16 Board Of Regents, The University Of Texas System Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II
US5206223A (en) * 1986-06-26 1993-04-27 Yeda Research And Development Co. Ltd. Method for inhibiting heparanase activity
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
IL86753A0 (en) * 1988-06-15 1988-11-30 Hadassah Med Org Pharmaceutical compositions for treatment of lupus
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
US5340932A (en) * 1989-08-18 1994-08-23 Ajorca S.A. Substances with heparin-like structure and their method of production
JP3188691B2 (ja) * 1989-08-23 2001-07-16 ハダサ メディカル オーガナイゼーション ヘパラナーゼを含む創傷治癒用組成物
DK148890D0 (da) * 1990-06-19 1990-06-19 Novo Nordisk As Farmaceutisk praeparat
US5733892A (en) * 1990-07-24 1998-03-31 Seikagaku Corporation Metastasis inhibitor composition comprising a phospholipid-linked glycosaminoglycan and method for inhibiting metastasis employing the same
AU647814B2 (en) * 1990-07-24 1994-03-31 Seikagaku Kogyo Kabushiki Kaisha Phospholipid- or lipid-combining glycosaminoglycan, production thereof, and cancer metastasis inhibitor
US6060296A (en) * 1991-07-03 2000-05-09 The Salk Institute For Biological Studies Protein kinases
US6750207B1 (en) * 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
WO1995002052A1 (en) * 1993-07-06 1995-01-19 F. Hoffmann-La Roche Ag Mammamodulin, a hormone-independent mammary tumor cells specific protein
FR2708198B1 (fr) * 1993-07-28 1995-10-20 Dior Christian Parfums Composition cosmétique ou pharmaceutique, notamment dermatologique contenant un extrait de Tephrosia, en particulier Tephrosia purpurea.
US6440445B1 (en) 1996-09-30 2002-08-27 Brigham & Women's Hospital Methods and compounds for treatment of abnormal uterine bleeding
US6190875B1 (en) * 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
US6699672B1 (en) 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US20030161823A1 (en) * 1998-08-31 2003-08-28 Neta Ilan Therapeutic and cosmetic uses of heparanases
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
JP2002504376A (ja) 1998-02-24 2002-02-12 ファルマシア・アンド・アップジョン・カンパニー ヒト血小板ヘパラナーゼポリペプチド、それをコードするポリヌクレオチド分子、およびヘパラナーゼ活性を改変する化合物の同定方法
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
AU2878600A (en) * 1999-03-01 2000-09-21 Hadasit Medical Research Services & Development Company Ltd Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
DK1240313T3 (da) 1999-12-22 2006-11-27 Ucb Sa Enzymer, som er homologe med heparanase og splejsningsvarianter deraf
US7781416B2 (en) 2000-01-25 2010-08-24 Sigma-Tau Research Switzerland S.A. Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
IT1316986B1 (it) 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
EP1276862A2 (en) * 2000-04-20 2003-01-22 Pharmacia & Upjohn Company Heparanase ii, a human heparanase paralog
CN1197587C (zh) * 2000-06-09 2005-04-20 中国科学院上海细胞生物学研究所 N－位脱硫酸肝素在预防和治疗炎症中的应用
CA2457719C (en) * 2001-09-12 2012-01-03 Benito Casu Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
US7285536B2 (en) * 2001-12-05 2007-10-23 Yeda Research And Development Co., Ltd. Anti-cancer therapeutic compounds
WO2004108065A2 (en) * 2003-06-09 2004-12-16 Insight Biopharmaceuticals Ltd. Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
WO2005076743A2 (en) * 2004-02-17 2005-08-25 Yeda Research And Development Co. Ltd. Disaccharide molecules and derivatives thereof and methods of using same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR81305E (fr) * 1959-01-29 1963-09-06 Roussel Uclaf Procédé de préparation de la nu-désulfo héparine et de ses dérivés acyles
EP0114589B1 (en) * 1982-12-20 1987-09-23 The President And Fellows Of Harvard College Inhibition of angiogenesis
GR79775B (da) * 1983-03-22 1984-10-31 Cegedur

Also Published As

Publication number Publication date
NO872674D0 (no) 1987-06-25
EP0254067A2 (en) 1988-01-27
AU7470587A (en) 1988-01-07
NO872674L (no) 1987-12-28
EP0254067A3 (en) 1988-09-14
DK331387D0 (da) 1987-06-26
US4882318A (en) 1989-11-21
IL79255A0 (en) 1986-09-30
JPS6388128A (ja) 1988-04-19

Similar Documents

Publication Publication Date Title
DK331387A (da) Praeparat til forhindring af metastase
DK404187A (da) Fremgangsmaade til fremstilling af thiazolderivater
DK643187A (da) Fremgangsmaade til fremstilling af basis-smoereolier
NO874467D0 (no) Fremgangsmaate for fremstilling av 3-pyrrolidinoler.
DK328382A (da) Fremgangsmaade til fremstilling af antihypertensive midler
DK549087D0 (da) Gangliosidbeslaegtede forbindelser og fremgangsmaade til fremstilling af samme
DK214585D0 (da) Fremgangsmaade til fremstilling af imidazorifamyciner
DK418386A (da) Kombinationspraeparat til behandling af malaria
DK537687D0 (da) Fremgangsmaade til fremstilling af n-substituerede piperazinoner
DK28788A (da) Fremgangsmaade til fremstilling af alkansulfonamider
NO873400D0 (no) Fremgangsmaate for fremstilling av sulfidfri alkalivaeske.
DK603987D0 (da) Fremgangsmaade til fremstilling af purin-9-ylalkylenoxymethylphosphonsyrer
DK53787D0 (da) Fremgangsmaade til fremstilling af carboxylsyreamider
NO168941C (no) Fremgangsmaate for fremstilling av mercaptoacylprolin.
DK533287A (da) Fremgangsmaade til fremstilling af azetidinoner
DK558487A (da) Fremgangsmaade til fremstilling af moertel
DK184687A (da) Fremgangsmaade til fremstilling af diacetonesorbose
NO880345L (no) Fremgangsmaate for fremstilling av alkyl-tert-butyletere.
DK130992A (da) Fremgangsmaade til fremstilling af angiotenxinomdannende enzyminhibitorer
DK234687D0 (da) Fremgangsmaade til fremstilling af ribitylxylidin
NO875253D0 (no) Fremgangsmaate for fremstilling av methyl-4-oxo-5-tetradecynoat.
DK564985A (da) Fremgangsmaade til fremstilling af alkylthioacetamidiner
DK256786D0 (da) Fremgangsmaade til fremstilling af triazolderivater
DK646188A (da) Fremgangsmaade til fremstilling af halogenalkyllactamer
DK26888A (da) Fremgangmsaade til fremstilling af diaminoalkanderivater

Legal Events

Date Code Title Description
A0 Application filed
AHB Application shelved due to non-payment